provided – Page 306 – Communicable Diseases Research

Temporal Variability and Social Heterogeneity in Disease Transmission: The Case of SARS in Hong Kong

Research Article

Published on 2009-08-212022-10-28
Journal: PLoS Computational Biology
[Category] Coronavirus, MERS,

Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway

Research Article

Published on 2008-11-072022-10-29
Journal: PLoS Pathogens
[Category] Coronavirus,

[키워드] 80R activity amino acid change analysis Anti-viral Anti-viral therapy Author block caused CDR Combination complementarity determining region component Cytidine deaminase dominant driving effective elicited Epidemic epitope escape mutant escape mutants escape mutation Evidence Evolution found generate human convalescent sera immune immune pressure IMPROVE Infected Infectious disease information introduced investigated Mutagenesis NAb natural infection neutralization neutralization activity neutralizing antibody non-immune outbreak pathway Pathways Positive selection Protein provided response responses against responsible SARS coronavirus SARS-CoV SARS-CoV spike protein Somatic Spike protein strain Strategy Support Therapies transfer Transmission viral variant virus virus viruses while zoonotic zoonotic transmission
[DOI] 10.1371/journal.ppat.1000197 PMC 바로가기 [Article Type] Research Article

Genome-Wide Analysis of Protein-Protein Interactions and Involvement of Viral Proteins in SARS-CoV Replication

Research Article

Published on 2008-10-012022-10-28
Journal: PLoS ONE
[Category] Coronavirus,

Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

Research Article

Published on 2006-12-262022-10-29
Journal: PLoS Medicine
[Category] Coronavirus, Fulltext, 조류인플루엔자,

[키워드] 2003 acute respiratory syndrome addition Administered Antisera bat bats Bearing candidate vaccine caused Cell cellular immune responses center characterized chimeric China Cluster coding Complete Consequences Control coronavirus cross death death rate death rates develop died different disease effective Efficacy eight elicit Epidemic etiological agent examined expressing finding flu found future infection Gene genetic material genetics glycoprotein group Guidance Heterologous heterologous challenge homologous homologous or heterologous homologous strain challenge Human human airway epithelial humans identify immune response immunized immunopathology infect Infected Infection information injected lung mice much higher neutralization nucleocapsid Older Outbreaks Particle pathological change pathology peaked phylogenetic analyses populations PROTECT Protein Proteins provide provided recombinant related virus related viruses replicated researcher reservoirs resource robust rodents S glycoprotein SARS Coronavirus SARS infection SARS virus SARS-CoV SARS-CoV N SARS-CoV S SARS-CoV S protein SARS-CoV vaccine SARS-CoV virus senescent severe severe pneumonia spike spike glycoprotein Spread strain Strains tested the disease the vaccine thought vaccination Vaccine vaccine candidate Vaccine design Vaccine development Vaccines variant Venezuelan equine encephalitis virus virus virus strain was used Web West Nile Virus World Health Organization zoonosis zoonotic
[DOI] 10.1371/journal.pmed.0030525 PMC 바로가기 [Article Type] Research Article

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants

Research Article

Published on 2006-07-042022-10-29
Journal: PLoS Medicine
[Category] Coronavirus,

[키워드] 2003 acute respiratory syndrome Administered affected against SARS-CoV Alter Amino acid anti-SARS-CoV antibody antibody antibody concentration Antigen antigens approach arising Bacteria binding blocked Blood breadth carried caused center China close contact close person-to-person contact Combination complementary Concentration Control convalescent SARS patient coronavirus Coverage CR3014 CR3022 died different disease disease severity dose Effect effective Epidemic Epidemics epitope escape experiment feasible ferret ferrets finding generate glycoprotein Guangdong Health healthy Hong Kong Human human cell human cells human macrophage Human monoclonal antibody humans immune Immune escape immunization immunize in vitro individual effects Infected infecting Infection infectious Infectious disease information interact Interaction International killing Laboratory less limit lung damage Lung pathology mAb mAbs measure monoclonal monoclonal antibody Mutation neutralization neutralized NO organism Patient pharyngeal Prevent prevented prevention producing Prophylaxis provided quarantine recognize recognizing reduce reduction repeated replicated required Research researcher residue responsible SARS epidemic SARS-CoV SARS-CoV infection screened shown sick Spread strain suppress synergistic synergistic fashion synergy tested the disease the receptor-binding domain Travel treat variant variants viral escape viral spread virus virus Virus neutralization virus strain virus-neutralizing viruses website Wikipedia World Health Organization
[DOI] 10.1371/journal.pmed.0030237 PMC 바로가기 [Article Type] Research Article

What Internet Services Would Patients Like From Hospitals During an Epidemic? Lessons From the SARS Outbreak in Toronto

Original Paper

Published on 2005-08-032022-10-30
Journal: Journal of Medical Internet Research
[Category] Coronavirus,

[키워드] 2003 acute respiratory syndrome affected age Analysis Care clinics communicable diseases, emerging conducted Descriptive statistics determine emergency situation English Epidemic expressed Health health condition health information Health Service help hospital identify IMPROVE infectious Infectious disease information information services international health Internet Laboratory lesson Like logistic regression model maintain mean Most patient objective organization outbreak pandemic Patient predictor professional promote provided public health Questionnaires Regression responsible restrict Result searched selected service Severe acute respiratory syndrome Toronto unique Web were used World wide web
[DOI] 10.2196/jmir.7.4.e46 PMC 바로가기 [Article Type] Original Paper

Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenza

Article

Published on 2005-05-122022-11-01
Journal: Journal of Clinical Virology
[Category] Coronavirus, Fulltext, 조류인플루엔자,

Topographic Changes in SARS Coronavirus–infected Cells at Late Stages of Infection

Research

Published on 2004-11-012022-10-31
Journal: Emerging Infectious Diseases
[Category] Coronavirus,

Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay

Article

Published on 2004-09-112022-11-01
Journal: Journal of virological methods
[Category] Coronavirus,

Laboratory Diagnosis of SARS

Research

Published on 2004-05-012022-10-31
Journal: Emerging Infectious Diseases
[Category] Coronavirus,